CAR T-Cell Therapy Market
According to Intent Market Research, the CAR T-Cell Therapy Market is expected to grow from USD 4.4 billion in 2023 at a CAGR of 32.5% to touch USD 31.2 billion by 2030. The CAR T-Cell Therapy Market is dominated by key players such as Autolus Therapeutics, Bristol-Myers Squibb Company, CARsgen Therapeutics Holdings Limited, CRISPR Therapeutics, Gilead Sciences and IASO Biotherapeutics.